188 related articles for article (PubMed ID: 28807496)
1. CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans.
Waickman AT; Ligons DL; Hwang S; Park JY; Lazarevic V; Sato N; Hong C; Park JH
Cytokine; 2017 Nov; 99():266-274. PubMed ID: 28807496
[TBL] [Abstract][Full Text] [Related]
2. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate inhibits expression of receptors for T cell regulatory cytokines and their downstream signaling in mouse CD4+ T cells.
Wang J; Pae M; Meydani SN; Wu D
J Nutr; 2012 Mar; 142(3):566-71. PubMed ID: 22323768
[TBL] [Abstract][Full Text] [Related]
4. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells.
Raffin C; Raimbaud I; Valmori D; Ayyoub M
J Immunol; 2011 Nov; 187(10):5196-202. PubMed ID: 21998454
[TBL] [Abstract][Full Text] [Related]
6. IL-15 and IL-15Ralpha in CD4+T cell immunity.
Van Belle T; Grooten J
Arch Immunol Ther Exp (Warsz); 2005; 53(2):115-26. PubMed ID: 15928580
[TBL] [Abstract][Full Text] [Related]
7. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development.
Vang KB; Yang J; Mahmud SA; Burchill MA; Vegoe AL; Farrar MA
J Immunol; 2008 Sep; 181(5):3285-90. PubMed ID: 18714000
[TBL] [Abstract][Full Text] [Related]
8. Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells.
Chen X; Howard OM; Oppenheim JJ
J Immunol; 2007 May; 178(10):6123-9. PubMed ID: 17475838
[TBL] [Abstract][Full Text] [Related]
9. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation.
Olsen SK; Ota N; Kishishita S; Kukimoto-Niino M; Murayama K; Uchiyama H; Toyama M; Terada T; Shirouzu M; Kanagawa O; Yokoyama S
J Biol Chem; 2007 Dec; 282(51):37191-204. PubMed ID: 17947230
[TBL] [Abstract][Full Text] [Related]
11. CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4(+)Foxp3(+) T and IL-17(+)CD4(+) Th17 cells.
Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Eo SK
J Neuroinflammation; 2016 Jul; 13(1):223. PubMed ID: 27439902
[TBL] [Abstract][Full Text] [Related]
12. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.
Burkett PR; Koka R; Chien M; Chai S; Boone DL; Ma A
J Exp Med; 2004 Oct; 200(7):825-34. PubMed ID: 15452177
[TBL] [Abstract][Full Text] [Related]
13. Retinoid X receptor agonists modulate Foxp3⁺ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation.
Takeuchi H; Yokota-Nakatsuma A; Ohoka Y; Kagechika H; Kato C; Song SY; Iwata M
J Immunol; 2013 Oct; 191(7):3725-33. PubMed ID: 23980207
[TBL] [Abstract][Full Text] [Related]
14. IL-15Ralpha is a negative regulator of TCR-activated proliferation in CD4+ T cells.
Lee JM; Chung CY; Chiang WW; Liou YH; Chen CF; Liao NS
J Immunol; 2004 Sep; 173(5):3155-64. PubMed ID: 15322176
[TBL] [Abstract][Full Text] [Related]
15. IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells.
Castellani ML; Anogeianaki A; Felaco P; Toniato E; De Lutiis MA; Shaik B; Fulcheri M; Vecchiet J; Tetè S; Salini V; Theoharides TC; Caraffa A; Antinolfi P; Frydas I; Conti P; Cuccurullo C; Ciampoli C; Cerulli G; Kempuraj D
J Biol Regul Homeost Agents; 2010; 24(2):131-5. PubMed ID: 20487626
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
[TBL] [Abstract][Full Text] [Related]
17. PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.
Sharabi A; Li H; Kasper IR; Pan W; Meidan E; Tsokos MG; Moulton VR; Tsokos GC
JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30912768
[TBL] [Abstract][Full Text] [Related]
18. SMAD2 is essential for TGF beta-mediated Th17 cell generation.
Malhotra N; Robertson E; Kang J
J Biol Chem; 2010 Sep; 285(38):29044-8. PubMed ID: 20656683
[TBL] [Abstract][Full Text] [Related]
19. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
[TBL] [Abstract][Full Text] [Related]
20. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.
Skapenko A; Kalden JR; Lipsky PE; Schulze-Koops H
J Immunol; 2005 Nov; 175(9):6107-16. PubMed ID: 16237107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
